Cannabis Bioscience International Holdings Unveils Nanoemulsion Cannabinoid Formula Aimed at Enhancing Female Fertility in Women 35+
Reuters
Oct 13
<a href="https://laohu8.com/S/CBIH">Cannabis Bioscience International</a> Holdings Unveils Nanoemulsion Cannabinoid Formula Aimed at Enhancing Female Fertility in Women 35+
Cannabis Bioscience International Holdings Inc. (CBIH) has announced the addition of a patent-pending nanoemulsion formulation aimed at supporting female fertility and reproductive function in women aged 35 and older. This innovation, which centers cannabinoids combined with antioxidants, polyphenols, fatty acids, and other bioactives, is designed to address age-related reproductive decline by targeting mitochondrial function, redox balance, and cytokine signaling in ovarian and endometrial tissues. The nanoemulsion delivery system improves the solubility and bioavailability of cannabinoids, potentially enhancing tissue exposure at reproductive sites. According to CBIH, the formulation is intended to optimize the follicular microenvironment and support implantation, serving as an adjunct to existing assisted reproductive technologies. The announcement did not specify if or when the research results have been or will be presented publicly.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cannabis Bioscience International Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 270001) on October 13, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.